A series of researches have demonstrated that hub genes in CRC, such as DHRS9 [4], GRIM-19 [5], EphA2 [6], and STYK1 [7], not only are involved in regulating a variety of cellular processes including cell proliferation, survival, differentiation, migration, and apoptosis but are also correlated with disease progression and prognosis of patients with CRC. Here, NDUFA13 is linked to colorectal carcinoma.